Geriatric Depression and Inappropriate Medication: Benefits of Interprofessional Team Cooperation in Nursing Homes

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Dec 10

PMID 34886164

Citations 3

Authors

Hana Vankova

Iva Holmerova

Ladislav Volicer

Affiliations

Soon will be listed here.

Abstract

An investigation of inappropriate medication use in treatment of depressivity in institutionalized older adults, based on a nurse-led evaluation of functional status and depressive symptoms in nursing home residents. A cross-sectional multicenter study was performed using records from 1087 residents cared for in fifteen nursing homes (NHs) in the Czech Republic. Inclusion criteria were being a permanent resident of one of the facilities, being 60 years of age or older, having a Geriatric Depression Scale score of 6 or more, and having a Mini Mental State examination score 10 or more. The final sample for analysis included 317 depressed NH residents. 52 percent of NH residents with depressivity had no antidepressant treatment. Benzodiazepines were the only medication in 16 percent of depressed residents, and were added to antidepressant treatment in 18 percent of residents. Benzodiazepine users had significantly higher GDS scores compared to non-users ( = 0.007). More than half of depressed NH residents remained without antidepressant treatment. Residents inappropriately treated with benzodiazepines were more depressed than residents treated with antidepressants only, or even not treated at all. Cooperation of the interprofessional team in the screening of depressive symptoms has the potential to improve the quality of care.

Citing Articles

Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study.

Sun C, Pola A, Su K, Lin B, Kablinger A, Trestman R Drug Alcohol Depend Rep. 2024; 12:100270.

PMID: 39247100 PMC: 11380165. DOI: 10.1016/j.dadr.2024.100270.

The (Mis)use of Psychotropic Drugs and Addiction to Anxiolytics among Older Adults Living at Home or in Retirement Homes: Implications for Quality of Life.

Kralj M, Solic K, Lovric R Healthcare (Basel). 2023; 11(21).

PMID: 37958052 PMC: 10647519. DOI: 10.3390/healthcare11212908.

The sociodemographic characteristics and clinical features of the late-life depression patients: results from the Beijing Anding Hospital mental health big data platform.

Wang X, Rao W, Chen X, Zhang X, Wang Z, Ma X BMC Psychiatry. 2022; 22(1):677.

PMID: 36324116 PMC: 9628045. DOI: 10.1186/s12888-022-04339-7.

References

Biering P . Helpful approaches to older people experiencing mental health problems: a critical review of models of mental health care. Eur J Ageing. 2019; 16(2):215-225. PMC: 6509324. DOI: 10.1007/s10433-018-0490-3. View

Moscati A, Flint J, Kendler K . CLASSIFICATION OF ANXIETY DISORDERS COMORBID WITH MAJOR DEPRESSION: COMMON OR DISTINCT INFLUENCES ON RISK?. Depress Anxiety. 2015; 33(2):120-7. PMC: 4729582. DOI: 10.1002/da.22432. View

Vink D, Aartsen M, Comijs H, Heymans M, Penninx B, Stek M . Onset of anxiety and depression in the aging population: comparison of risk factors in a 9-year prospective study. Am J Geriatr Psychiatry. 2009; 17(8):642-52. DOI: 10.1097/jgp.0b013e3181a65228. View

Hanlon J, Handler S, Castle N . Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc. 2010; 11(5):320-4. PMC: 2925025. DOI: 10.1016/j.jamda.2010.01.007. View

Lai I, Wang M, Wu B, Wu H, Lian P . The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use. J Clin Pharm Ther. 2010; 36(5):577-84. DOI: 10.1111/j.1365-2710.2010.01213.x. View

de Craen A, Heeren T, Gussekloo J . Accuracy of the 15-item geriatric depression scale (GDS-15) in a community sample of the oldest old. Int J Geriatr Psychiatry. 2002; 18(1):63-6. DOI: 10.1002/gps.773. View

Dunn R, Harrison D, Ripley T . The beers criteria as an outpatient screening tool for potentially inappropriate medications. Consult Pharm. 2011; 26(10):754-63. DOI: 10.4140/TCP.n.2011.754. View

Fick D, Cooper J, Wade W, Waller J, Maclean J, Beers M . Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003; 163(22):2716-24. DOI: 10.1001/archinte.163.22.2716. View

Vankova H, Holmerova I, Machacova K, Volicer L, Veleta P, Celko A . The effect of dance on depressive symptoms in nursing home residents. J Am Med Dir Assoc. 2014; 15(8):582-7. DOI: 10.1016/j.jamda.2014.04.013. View

10.

Billioti de Gage S, Begaud B, Bazin F, Verdoux H, Dartigues J, Peres K . Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012; 345:e6231. PMC: 3460255. DOI: 10.1136/bmj.e6231. View

11.

Almeida O, Almeida S . Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry. 1999; 14(10):858-65. DOI: 10.1002/(sici)1099-1166(199910)14:10<858::aid-gps35>3.0.co;2-8. View

12.

Chen K, Reese E, Kim H, Rapoport S, Rao J . Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis. 2011; 26(4):755-766. PMC: 3188700. DOI: 10.3233/JAD-2011-110002. View

13.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

14.

Alexopoulos G . Pharmacotherapy for late-life depression. J Clin Psychiatry. 2011; 72(1):e04. PMC: 3314291. DOI: 10.4088/JCP.7085tx2cj. View

15.

Leggett A, Kavanagh J, Zivin K, Chiang C, Kim H, Kales H . The Association Between Benzodiazepine Use and Depression Outcomes in Older Veterans. J Geriatr Psychiatry Neurol. 2015; 28(4):281-7. PMC: 4927262. DOI: 10.1177/0891988715598227. View

16.

Paquin A, Zimmerman K, Rudolph J . Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf. 2014; 13(7):919-34. DOI: 10.1517/14740338.2014.925444. View

17.

MAHONEY F, BARTHEL D . FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965; 14:61-5. View

18.

Beekman A, de Beurs E, van Balkom A, Deeg D, van Dyck R, van Tilburg W . Anxiety and depression in later life: Co-occurrence and communality of risk factors. Am J Psychiatry. 2000; 157(1):89-95. DOI: 10.1176/ajp.157.1.89. View

19.

Cumming R, Le Couteur D . Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003; 17(11):825-37. DOI: 10.2165/00023210-200317110-00004. View

20.

Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P . Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012; 67(6):698-704. DOI: 10.1093/gerona/glr233. View